Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 163, Issue 1, Pages 29-43Publisher
WILEY
DOI: 10.1111/j.1476-5381.2010.01199.x
Keywords
asthma; COPD; inflammation; p38 MAP kinase; histone deacetylase; steroid resistance; oxidative stress; beta(2)-adrenoceptors
Categories
Funding
- AstraZeneca
- Boehringer Ingelheim
- Chiesi
- GlaxoSmithKline
- Novartis
- Pfizer
- Teva
- UCB
Ask authors/readers for more resources
LINKED ARTICLES This article is part of a themed issue on Respiratory Pharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue-1.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
